Choosing how to physically get into the chest is one of the earliest decisions made in planning a cardiac operation, and it is rarely a trivial one. The debate of minimally invasive cardiac surgery vs sternotomy is not really about which access route is universally superior — it is about which trade-offs are acceptable for a specific patient, a specific procedure, and a specific surgical team's experience. Both approaches remain widely used, and both have a substantial track record. This article lays out how the two compare across common considerations, without suggesting that one approach should replace the other in general.
What Is the Basic Difference Between These Two Access Routes?
A full sternotomy involves dividing the breastbone lengthwise to open the chest widely, giving the surgical team direct, unobstructed access to the heart and great vessels. It has been the standard access route for open cardiac surgery for decades and remains the default approach for many operations, particularly complex or emergent cases. Minimally invasive cardiac surgery (MICS), by contrast, uses one or more small incisions — commonly a mini-thoracotomy between the ribs, or a partial rather than full sternal division — to reach the heart through a much narrower window, typically with the assistance of specialized shafted instruments and endoscopic visualization. Some MICS approaches are described as sternal-sparing because they avoid dividing the sternum entirely, while others involve only a partial split. The underlying surgical goal is the same in both cases; what differs is the size and location of the access point used to reach it.
What Are the Typical Advantages Associated With Full Sternotomy?
Full sternotomy offers the surgical team the widest possible field of view and direct manual access to the heart, which can simplify management of unexpected findings or complications during the operation. Because the technique is long-established, it is familiar to virtually every cardiac surgical team and applicable across a broad range of procedures, including complex multi-valve repairs, extensive coronary bypass grafting, and aortic surgery, where wide exposure is often considered valuable. In emergent situations, or when rapid access to the heart is needed, the speed and directness of a sternotomy can be a meaningful consideration. Because the sternum is a single bone that heals as one structure, sternal precautions during recovery are well understood and standardized across most cardiac surgery programs.
What Are the Typical Considerations Associated With MICS Approaches?
Approaches described as MICS are generally associated with a smaller visible incision and, in some cases reported in the literature, comparatively shorter hospital stays or a faster return to normal activity for suitable candidates, though outcomes vary by patient, procedure, and surgical team experience. Avoiding or minimizing sternal division may reduce certain sternal-specific concerns, such as sternal wound complications, though thoracotomy incisions carry their own distinct set of considerations, including intercostal nerve-related discomfort. MICS procedures generally require more specialized instrumentation, including shafted and angled tools, along with peripheral cannulation strategies for cardiopulmonary bypass, and surgical teams typically need dedicated training and case experience before adopting these techniques routinely. Not every patient or every procedure is anatomically suited to a small-incision approach — factors such as extensive calcification, certain anatomical variants, or prior chest surgery can make a minimally invasive approach more technically difficult or unsuitable in a given case.
How Should Patients Think About Recovery Expectations?
Recovery comparisons between the two approaches are often discussed in terms of hospital length of stay, pain in the early postoperative period, and time to resume normal activities, but individual recovery is influenced by far more than the access route alone, including the specific procedure performed, overall health status, and any complications encountered. Sternal precautions, such as restrictions on lifting or upper body strain while the sternum heals, are a well-known part of recovery after a full sternotomy, while recovery after a thoracotomy-based MICS approach involves its own set of activity guidance centered on the incision and rib area. Neither recovery pathway should be assumed to be uniformly easier, since patient-specific factors frequently outweigh generalizations tied to the incision type alone.
Instruments intended to support small-incision cardiac access, including INVAMED's NeoCardia minimally invasive cardiac surgery instruments, are one example of the specialized tooling this approach relies on; the broader category of cardiac access and bypass instrumentation is available on the Cardiac Surgery Instruments category page.
Is minimally invasive cardiac surgery always a better option than sternotomy?
Not necessarily. Neither approach is universally better; each carries a different set of advantages and considerations. The suitability of either route depends on the specific procedure being performed, the patient's individual cardiac and chest anatomy, and the experience of the surgical team, all of which are assessed on a case-by-case basis.
Who decides which access approach is used for a given patient?
The operating cardiac surgeon makes this determination, typically after reviewing diagnostic imaging, the planned procedure, and the patient's overall clinical picture. Patients are generally involved in this discussion as part of informed consent, but the anatomical and technical assessment is a clinical judgment made by the surgical team.
Can a surgery planned as minimally invasive be switched to a full sternotomy during the operation?
Yes. If the surgical team encounters findings that make continued minimally invasive access unsafe or impractical, they can convert to a full sternotomy at any point in the procedure. This contingency is a standard part of surgical planning and is typically discussed with patients beforehand.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.